|
||
Tenoxicam Uses |
||
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
Tenoxicam is used to reduce pain and inflammation (swelling) of the muscles, tendons, and joints in diseases like arthritis or in short-term injuries, strains, or sprains.
Novo-Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: 20 mg as a single dose, taken at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest possible duration.
Acute musculoskeletal disorders; Osteoarthritis; Rheumatoid arthritis
Adult: Initially, 20 mg IM/IV as a single dose given for 1-2 days, to be continued w/ the oral form, administered at the same time each day. Treatment duration: Up to 7 days for acute musculoskeletal disorders and up to 14 days for severe cases.
Elderly: Use the lowest effective dose for the shortest duration.
Reconstitution: Dissolve lyophilisate in 2 mL of sterile water for inj.
FELDENE is highly protein bound, and therefore, might be expected to displace other protein-bound drugs. Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.
Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels.
Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. It is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing FELDENE.
Cardiovascular
Edema; weight gain; CHF; alterations in BP; vasodilation; palpitations; tachycardia.
CNS
Headache; malaise; dizziness; somnolence; vertigo; depression; insomnia; nervousness.
Dermatologic
Pruritus; rash; sweating; erythema; bruising; desquamation; erythema multiforme; toxic epidermal necrolysis.
EENT
Tinnitus; swollen eyes; blurred vision; eye irritation; rhinitis; pharyngitis.
GI
Epigastric distress; nausea; vomiting; anorexia; constipation; stomatitis; abdominal discomfort; diarrhea; flatulence; abdominal pain; indigestion; toxicity (bleeding, ulceration, perforation); heartburn; dyspepsia; anorexia.
Genitourinary
Hematuria; proteinuria; increased BUN and serum creatinine; acute renal insufficiency and failure; papillary necrosis; interstitial nephritis; nephrotic syndrome; hyperkalemia; hyponatremia.
Hematologic
Increased bleeding time; decreased Hgb and Hct; anemia; leukopenia; eosinophilia, thrombocytopenia.
Hepatic
Increased LFTs; elevated liver enzymes.
Respiratory
Bronchospasm; laryngeal edema; dyspnea; hemoptysis; shortness of breath.
Hypersensitivity to Tenoxicam, aspirin or other NSAIDs. History of or active peptic ulceration, GI bleeding (melaena, haematemesis) or severe gastritis; severe heart failure. Last trimester of pregnancy.
Tenoxicam
Unit description / dosage (Manufacturer) | Price, USD |
Tablet; Oral; Tenoxicam 20 mg | |
Capsule; Oral; Tenoxicam 20 mg | |
Apo-Tenoxicam 20 mg Tablet | $ 1.21 |
List of Tenoxicam substitutes (brand and generic names): | |
Tenoxen (Brazil) | |
Tenoxicam 20 | |
Tenoxicam AA Pharma (Canada) | |
Tenoxicam AFT (New Zealand) | |
Tenoxicam Alternova (Denmark) | |
Tenoxicam American Generics (Colombia) | |
Tenoxicam Arena (Romania) | |
Tenoxicam Bidiphar (Vietnam) | |
Tenoxicam Bidiphar 20 mg x 3 Blister x 10 Tablet | |
Tenoxicam Bidiphar 20 mg/2 mL x 1 Bottle in 1 tube dung mobi 2 mL | |
Tenoxicam el obour (Egypt) | |
Tenoxicam EMS (Brazil) | |
Tenoxicam Etyc (Colombia) | |
Tenoxicam Eurofarma (Brazil) | |
Tenoxicam Generis (Portugal) | |
Tenoxicam Genfar (Peru) | |
Tenoxicam Geolab (Brazil) | |
Tenoxicam Laropharm (Romania) | |
Tenoxicam LPH (Romania) | |
Tenoxicam Medicon (Greece) | |
Tenoxicam Medoquimica (Brazil) | |
Tenoxicam Merck (Portugal) | |
Tenoxicam Mintlab (Chile) | |
Tenoxicam Mylan (Portugal) | |
Tenoxicam Neo Quimica (Brazil) | |
Tenoxicam Sandoz (Brazil) | |
Tenoxicam Sanitas (Chile) | |
Tenoxicam Sos (Italy) | |
Tenoxicam [Usan:Ban:Inn:Jan] | |
Tenoxicam-GPL (Vietnam) | |
Tenoxicam-GPL 20 mg x 2 Blister x 10 Tablet | |
Tenoxicamum | |
Tenoxicamum [Inn-Latin] | |
Tenoxican (Colombia) | |
Tenoxil (Thailand) | |
Tenoxil 20 mg x 2 Blister x 8 Tablet (Olan-kemed) | |
Tenoxil 20 mg x 200's (Olan-kemed) | $ 22.12 |
Tenoxin (Venezuela) | |
Tenoxitic (Vietnam) | |
Tenoxitic 20 mg x 10 Tablet | |
Tenoxman (Thailand) | |
Tenoxman 20 mg x 25 x 10's | |
Tenoxman 20 mg x 500's | |
Tentepanil (Greece) | |
Tenxil (Thailand) | |
Texicam (Bangladesh) | |
Thenil (Indonesia) | |
Thenil 20 mg x 5 x 10's (Interbat) | $ 14.26 |
See 235 substitutes for Tenoxicam |
Users | % | ||
---|---|---|---|
Not expensive | 1 | 100.0% |
Users | % | ||
---|---|---|---|
16-29 | 1 | 100.0% |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|